Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    16635791 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Unknown  T&B Depletion Non Malignant
Condition: Graft Versus Host Disease
Interventions: Biological: polyclonal antibody;   Drug: Rituximab;   Drug: Treosulfan;   Drug: Fludarabine;   Drug: Thiotepa;   Drug: Cyclosporine A;   Drug: Methotrexate

Study has passed its completion date and status has not been verified in more than two years.